Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M9,352Revenue $M619Net Margin (%)-5.6Altman Z-Score12.1
Enterprise Value $M8,961EPS $-0.2Operating Margin %-15.2Piotroski F-Score6
P/E(ttm)--Beneish M-Score-2.7Pre-tax Margin (%)-3.6Higher ROA y-yN
Price/Book6.610-y EBITDA Growth Rate %--Quick Ratio8.4Cash flow > EarningsY
Price/Sales14.45-y EBITDA Growth Rate %--Current Ratio8.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %34.1ROA % (ttm)-1.9Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-2.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M149ROIC % (ttm)-10.4Gross Margin Increase y-yY

Gurus Latest Trades with ALKS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ALKSVanguard Health Care Fund 2015-03-31 Add$58.24 - $73.64
($68.32)
$ 64.47-6%Add 0.05%6,229,583
ALKSKen Fisher 2014-12-31 Add$40.23 - $58.88
($51.09)
$ 64.4726%Add 10.18%107,164
ALKSVanguard Health Care Fund 2014-12-31 Add$40.23 - $58.88
($51.09)
$ 64.4726%Add 0.05%6,226,383
ALKSVanguard Health Care Fund 2014-09-30 Add0.01%$41.54 - $51.75
($44.82)
$ 64.4744%Add 1.42%6,223,083
ALKSKen Fisher 2014-09-30 Add$41.54 - $51.52
($44.73)
$ 64.4744%Add 75.86%97,264
ALKSVanguard Health Care Fund 2014-06-30 Add0.13%$41.1 - $50.94
($46.06)
$ 64.4740%Add 18.45%6,135,913
ALKSKen Fisher 2014-06-30 Buy 0.01%$41.1 - $50.94
($46.06)
$ 64.4740%New holding55,309
ALKSVanguard Health Care Fund 2014-03-31 Add0.19%$40.07 - $53.82
($47.32)
$ 64.4736%Add 41.07%5,180,238
ALKSVanguard Health Care Fund 2013-12-31 Add0.1%$30.17 - $41.12
($36.93)
$ 64.4775%Add 28.18%3,672,087
ALKSVanguard Health Care Fund 2013-09-30 Add0.07%$28.66 - $35.35
($32.58)
$ 64.4798%Add 26.21%2,864,896
ALKSJoel Greenblatt 2013-09-30 Sold Out -0.03%$28.66 - $35.35
($32.58)
$ 64.4798%Sold Out0
ALKSVanguard Health Care Fund 2013-06-30 Add0.11%$22.35 - $33.72
($29.15)
$ 64.47121%Add 84.09%2,269,902
ALKSJoel Greenblatt 2013-06-30 Buy 0.03%$22.35 - $33.72
($29.15)
$ 64.47121%New holding26,624
ALKSVanguard Health Care Fund 2013-03-31 Add0.04%$18.52 - $23.81
($21.87)
$ 64.47195%Add 47.24%1,233,024
ALKSVanguard Health Care Fund 2012-06-30 Add$15.12 - $18.64
($16.96)
$ 64.47280%Add 6.28%837,400
ALKSVanguard Health Care Fund 2012-03-31 Buy 0.07%$16.14 - $19.5
($16.48)
$ 64.47291%New holding787,900
ALKSFirst Eagle Investment 2010-03-31 Sold Out -0.01%$9.41 - $14.01
($11.62)
$ 64.47455%Sold Out0
ALKSGeorge Soros 2010-03-31 Sold Out $9.41 - $14.01
($11.62)
$ 64.47455%Sold Out0
ALKSGeorge Soros 2009-12-31 Buy $7.58 - $9.88
($8.72)
$ 64.47639%New holding22,800
ALKSFirst Eagle Investment 2009-09-30 Buy 0.01%$8.75 - $11.65
($10.13)
$ 64.47536%New holding100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ALKS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ALKS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Cooke ShanePresident, Alkermes plc 2015-06-23Sell18,000$66.84-1.63view
MITCHELL PAUL JDirector 2015-06-17Sell15,500$65.11view
Pugh Gordon GSVP, COO & CRO, Alkermes, Inc. 2015-06-16Sell32,977$63.114.18view
FRATES JAMES MSVP & CFO, Alkermes plc 2015-06-16Sell10,000$58.6312.14view
BREYER ROBERT ADirector 2015-06-01Sell2,000$60.788.18view
MITCHELL PAUL JDirector 2015-06-01Sell1,500$60.788.18view
Peterson RebeccaSVP, Corporate Communications 2015-06-01Sell21,983$60.059.49view
Peterson RebeccaSVP, Corporate Communications 2015-05-26Sell1,322$60.498.7view
Cooke ShanePresident, Alkermes plc 2015-05-26Sell18,000$60.319.02view
Peterson RebeccaSVP, Corporate Communications 2015-05-22Sell28,558$61.716.55view

Quarterly/Annual Reports about ALKS:

News about ALKS:

Articles On GuruFocus.com
wait for positive ea Apr 06 2013 
comment on ALKS Mar 09 2013 
Best Health Care Investor Edward Owens Buys One New Health Care Stock in First Quarter Apr 30 2012 
Weekly CEO Sells Highlight: Herbalife, CNO Financial Group, Alkermes plc, and TransDigm Oct 08 2011 
Alkermes Inc. Reports Operating Results (10-Q) Feb 03 2011 
Weekly Guru Bargains Highlights: SKX, VRX, ALKS, DF, SVU Dec 05 2010 
Alkermes Inc. Reports Operating Results (10-Q) Nov 04 2010 
Alkermes Inc. Reports Operating Results (10-K) May 21 2010 
Alkermes Inc. Reports Operating Results (10-Q) Feb 04 2010 
Opportunistic Coat-tailing Jan 05 2010 

More From Other Websites
Edited Transcript of ALKS conference call or presentation 23-Jun-15 12:00pm GMT Jun 24 2015
Alkermes Plc Conference Call to Discuss Data of ALKS 3831 for Treatment of Schizophrenia scheduled... Jun 23 2015
The CEO who quit cigarettes for his stock's health Jun 19 2015
Jim Cramer's Top Takeaways: Palo Alto Networks, Tesla, Ambarella, Allergan, Wingstop, Alkermes Jun 18 2015
Jim Cramer's 'Mad Money' Recap: Thanks for Nothing, Janet Yellen Jun 17 2015
Cramer Remix: Are you smarter than Janet Yellen? Jun 17 2015
Alkermes (ALKS) in Focus: Stock Rises 10.1% in Session - Tale of the Tape Jun 17 2015
Alkermes (ALKS) Stock Gains After Announcing Presentation at Annual ASCP Meeting Jun 16 2015
Alkermes to Present Data From Late-Stage CNS Portfolio at Upcoming American Society of Clinical... Jun 16 2015
Alkermes to Present Data From Late-Stage CNS Portfolio at Upcoming American Society of Clinical... Jun 16 2015
Alkermes to Present Data From Late-Stage CNS Portfolio at Upcoming American Society of Clinical... Jun 16 2015
Aripiprazole Lauroxil Phase 3 Schizophrenia Study Results Published in Journal of Clinical... Jun 09 2015
Aripiprazole Lauroxil Phase 3 Schizophrenia Study Results Published in Journal of Clinical... Jun 09 2015
Aripiprazole Lauroxil Phase 3 Schizophrenia Study Results Published in Journal of Clinical... Jun 09 2015
Coverage initiated on Alkermes by Guggenheim Jun 09 2015
Alkermes’ Corporate Presentation to be Webcast At The Goldman Sachs 36th Annual Global Healthcare... Jun 02 2015
Alkermes’ Corporate Presentation to be Webcast At The Goldman Sachs 36th Annual Global Healthcare... Jun 02 2015
Alkermes’ Corporate Presentation to be Webcast At The Goldman Sachs 36th Annual Global Healthcare... Jun 02 2015
ALKERMES PLC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters... May 29 2015
Alkermes to Present Clinical Data on ALKS 8700 at Annual Meeting of the Consortium of Multiple... May 29 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK